These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 38012342)

  • 1. Cardiovascular Comorbidities Do Not Impact Prostate Artery Embolisation (PAE) Outcomes: Retrospective Analysis of the National UK-ROPE Registry.
    Vigneswaran G; Maclean D; Doshi N; Harris M; Bryant TJC; Hacking NC; Somani B; Modi S
    Cardiovasc Intervent Radiol; 2024 Jan; 47(1):115-120. PubMed ID: 38012342
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Randomised Clinical Trial of Prostatic Artery Embolisation Versus a Sham Procedure for Benign Prostatic Hyperplasia.
    Pisco JM; Bilhim T; Costa NV; Torres D; Pisco J; Pinheiro LC; Oliveira AG
    Eur Urol; 2020 Mar; 77(3):354-362. PubMed ID: 31831295
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prostate artery embolisation: an all-comers, single-operator experience in 159 patients with lower urinary tract symptoms, urinary retention, or haematuria with medium-term follow-up.
    Thulasidasan N; Kok HK; Elhage O; Clovis S; Popert R; Sabharwal T
    Clin Radiol; 2019 Jul; 74(7):569.e1-569.e8. PubMed ID: 30955835
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and safety of prostate artery embolization for benign prostatic hyperplasia: an observational study and propensity-matched comparison with transurethral resection of the prostate (the UK-ROPE study).
    Ray AF; Powell J; Speakman MJ; Longford NT; DasGupta R; Bryant T; Modi S; Dyer J; Harris M; Carolan-Rees G; Hacking N
    BJU Int; 2018 Aug; 122(2):270-282. PubMed ID: 29645352
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prostatic arterial embolization for the treatment of lower urinary tract symptoms caused by benign prostatic hyperplasia: a comparative study of medium- and large-volume prostates.
    Wang M; Guo L; Duan F; Yuan K; Zhang G; Li K; Yan J; Wang Y; Kang H
    BJU Int; 2016 Jan; 117(1):155-64. PubMed ID: 25851432
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Embolisation of prostatic arteries as treatment of moderate to severe lower urinary symptoms (LUTS) secondary to benign hyperplasia: results of short- and mid-term follow-up.
    Pisco JM; Rio Tinto H; Campos Pinheiro L; Bilhim T; Duarte M; Fernandes L; Pereira J; Oliveira AG
    Eur Radiol; 2013 Sep; 23(9):2561-72. PubMed ID: 23370938
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prostatic Artery Embolization (PAE) and Transurethral Resection of the Prostate (TURP) have a Differential Impact on Lower Urinary Tract Symptoms (LUTS): Retrospective Analysis of the Multicentre UK-ROPE (UK Register of Prostate Embolization) Study.
    Vigneswaran G; Maclean D; Hadi M; Maher B; Modi S; Bryant T; Harris M; Hacking N
    Cardiovasc Intervent Radiol; 2021 Jul; 44(7):1095-1102. PubMed ID: 33825062
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Non-inferiority, randomised, open-label clinical trial on the effectiveness of transurethral microwave thermotherapy compared to prostatic artery embolisation in reducing severe lower urinary tract symptoms in men with benign prostatic hyperplasia: study protocol for the TUMT-PAE-1 trial.
    Kristensen-Alvarez A; Fode M; Stroomberg HV; Nielsen KK; Arch A; Lönn LB; Taudorf M; Widecrantz SJ; Røder A
    Trials; 2024 Sep; 25(1):574. PubMed ID: 39223593
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of Clinical Outcomes of Prostatic Artery Embolization with 50-μm Plus 100-μm Polyvinyl Alcohol (PVA) Particles versus 100-μm PVA Particles Alone: A Prospective Randomized Trial.
    Wang MQ; Zhang JL; Xin HN; Yuan K; Yan J; Wang Y; Zhang GD; Fu JX
    J Vasc Interv Radiol; 2018 Dec; 29(12):1694-1702. PubMed ID: 30297313
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Technical and Imaging Outcomes from the UK Registry of Prostate Artery Embolization (UK-ROPE) Study: Focusing on Predictors of Clinical Success.
    Hacking N; Vigneswaran G; Maclean D; Modi S; Dyer J; Harris M; Bryant T
    Cardiovasc Intervent Radiol; 2019 May; 42(5):666-676. PubMed ID: 30603967
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prostatic Artery Embolization Using 100-300-μm Trisacryl Gelatin Microspheres to Treat Lower Urinary Tract Symptoms Attributable to Benign Prostatic Hyperplasia: A Single-Center Outcomes Analysis with Medium-Term Follow-up.
    Ayyagari R; Powell T; Staib L; Chapiro J; Raja A; Bhatia S; Chai T; Schoenberger S; Devito R
    J Vasc Interv Radiol; 2020 Jan; 31(1):99-107. PubMed ID: 31771896
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of 5-Alpha-Reductase Inhibitors Use at the Time of Prostatic Artery Embolization for Treatment of Benign Prostatic Obstruction.
    Cardarelli-Leite L; de Assis AM; Moreira AM; Antunes AA; Cerri GG; Srougi M; Carnevale FC
    J Vasc Interv Radiol; 2019 Feb; 30(2):228-232. PubMed ID: 30717954
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Voiding and Storage Domain-Specific Symptom Score Outcomes After Prostate Artery Embolization for Lower Urinary Tract Symptoms and Urinary Retention.
    Powell T; Staib L; Liu B; Bhatia S; Chai T; Ayyagari R
    Urology; 2021 Oct; 156():216-224. PubMed ID: 33961894
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prostate artery embolisation for benign prostatic hyperplasia: a systematic review and meta-analysis.
    Malling B; Røder MA; Brasso K; Forman J; Taudorf M; Lönn L
    Eur Radiol; 2019 Jan; 29(1):287-298. PubMed ID: 29948079
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prostate artery embolization has long term efficacy for treatment of severe lower urinary tract symptoms from giant prostatic hyperplasia.
    Somwaru AS; Metting S; Flisnik LM; Nellamattathil MG; Sharma A; Katabathina VS
    BMC Urol; 2020 Oct; 20(1):153. PubMed ID: 33032577
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prostatic Artery Embolization Allows to Maintain Full Sexual Activity in Patients Suffering from Bothersome Lower Urinary Tracts Symptoms related to Benign Prostatic Hyperplasia.
    Marzano L; Thiounn N; Pereira H; Pellerin O; Dariane C; Del Giudice C; Amouyal G; Dean C; Sapoval M
    Cardiovasc Intervent Radiol; 2020 Aug; 43(8):1202-1207. PubMed ID: 32494835
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Randomized Comparison of Prostatic Artery Embolization versus Transurethral Resection of the Prostate for Treatment of Benign Prostatic Hyperplasia.
    Insausti I; Sáez de Ocáriz A; Galbete A; Capdevila F; Solchaga S; Giral P; Bilhim T; Isaacson A; Urtasun F; Napal S
    J Vasc Interv Radiol; 2020 Jun; 31(6):882-890. PubMed ID: 32249193
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prostatic Artery Embolisation Versus Transurethral Resection of the Prostate for Benign Prostatic Hyperplasia: 2-yr Outcomes of a Randomised, Open-label, Single-centre Trial.
    Abt D; Müllhaupt G; Hechelhammer L; Markart S; Güsewell S; Schmid HP; Mordasini L; Engeler DS
    Eur Urol; 2021 Jul; 80(1):34-42. PubMed ID: 33612376
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of Prostatic Artery Embolization on the Dynamic Component of Benign Prostate Hyperplasia as Assessed by Ultrasound Elastography: A Pilot Series.
    de Assis AM; Moreira AM; Carnevale FC; Marcelino ASZ; de Oliveira Cerri LM; Antunes AA; Srougi M; Cerri GG
    Cardiovasc Intervent Radiol; 2019 Jul; 42(7):1001-1007. PubMed ID: 30993369
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outcome prediction of prostatic artery embolization: post hoc analysis of a randomized, open-label, non-inferiority trial.
    Abt D; Müllhaupt G; Mordasini L; Güsewell S; Markart S; Zumstein V; Kessler TM; Schmid HP; Engeler DS; Hechelhammer L
    BJU Int; 2019 Jul; 124(1):134-144. PubMed ID: 30499637
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.